Socket Shield Technique With or Without Flap Elevation

Sponsor
Kutahya Health Sciences University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05492838
Collaborator
(none)
30
1
2
64.5
0.5

Study Details

Study Description

Brief Summary

It is aimed to compare the bone changes and the amount of marginal bone loss after prosthetic loading around the immediately placed implants using the Socket Shield Technique with or without flap elevation.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Immediate implantation with the Socket Shield Technique
N/A

Detailed Description

Temporary prostheses will be applied to patients in the flap and flapless surgery group 1 week after the surgical procedure, and permanent prostheses will be placed 3 months later. From this date, clinical controls will be made in the 1st, 3rd, 6th months and 1st year.

During these controls, biological complications (peri-implant mucositis, peri-implantitis), implant failure and survival rates, and complications related to the socket shield (socket shield exposure, infection) will be evaluated. Marginal bone loss around the implants and bone resorption in the horizontal and vertical directions will be compared between the two groups with cone beam computed tomography taken at the 1st year follow-up.

The Oral Health-Related Quality of Life Scale will be applied in the session where the temporary prosthesis is applied 1 week after the surgery, in the 1st month clinical control and in the 3rd and 6th month clinical control after the permanent prosthesis application, in order to evaluate the quality of life related to the surgical and prosthetic application of the patients in both groups, and comparisons between groups will be made.

In addition, intraoral photographs will be taken from the patients for aesthetic evaluation before the surgical procedure, at the 1st, 3rd and 6th month clinical control sessions. Pink Aesthetic Score (PES) and White Aesthetic Score (BES) will be evaluated on the photographs, and a comparison will be made between groups in terms of scores.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Clinical and Radiographic Evaluation of Socket Shield Technique With or Without Flap Elevation
Actual Study Start Date :
Jul 18, 2019
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Flapless Surgery

Procedure: Immediate implantation with the Socket Shield Technique
Immediate implant surgery applied with the Socket Shield Technique

Active Comparator: Surgery With Flap Elevation

Procedure: Immediate implantation with the Socket Shield Technique
Immediate implant surgery applied with the Socket Shield Technique

Outcome Measures

Primary Outcome Measures

  1. Change from baseline marginal bone loss at 12 months [Baseline, 12th month]

    Measurement of marginal bone loss change between baseline and 12th month by cone beam computed tomography

Secondary Outcome Measures

  1. Change of peri-implant pocket depth between baseline and follow-up periods [Baseline, 1st month, 3rd month, 6th month, 12th month]

    Clinical measurement of change in peri-implant pocket depth between follow-up periods using probe

  2. Change of modified plaque index between baseline and follow-up periods [Baseline, 1st month, 3rd month, 6th month, 12th month]

    Clinical measurement of change in modified plaque index between follow-up periods using probe

  3. Change of modified bleeding index between baseline and follow-up periods [Baseline, 1st month, 3rd month, 6th month, 12th month]

    Clinical measurement of change in modified bleeding index between follow-up periods using probe

  4. Change in the width of keratinized mucosa between follow-up periods [Baseline, 1st month, 3rd month, 6th month, 12th month]

    Clinical measurement of change in the keratinized mucosa width between follow-up periods using probe

  5. Change in the mucosal recession between follow-up periods [Baseline, 1st month, 3rd month, 6th month, 12th month]

    Clinical measurement of change in the mucosal recession between follow-up periods using probe

  6. Change in the mucosal thickness between follow-up periods [Baseline, 1st month, 3rd month, 6th month, 12th month]

    Clinical measurement of change in the mucosal thickness between follow-up periods using spreader

  7. Visual analog scale [Baseline, 1st week, 1st month, 3rd month, 6th month, 12th month]

    On a scale of 0-10, with 0 indicating the worst and 10 indicating the best choice

  8. Oral health impact profile questionnaire [Baseline, 1st week, 1st month, 3rd month, 6th month, 12th month]

    A questionnaire consisting of 14 items

  9. Pink aesthetic score [Baseline, 1st week, 1st month, 3rd month, 6th month, 12th month]

    An index with a minimum score of 0 and a maximum score of 14

  10. White aesthetic score [Baseline, 1st week, 1st month, 3rd month, 6th month, 12th month]

    An index with a minimum score of 0 and a maximum score of 10

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 62 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Being systemically healthy (ASA classification I-II)

  • Being over 18 years old

  • Not smoking

  • Having good oral hygiene

  • Upper incisors and premolars that cannot be restored and have extraction indications

  • Periodontally healthy, non-mobile teeth

  • The amount and quality of bone suitable for immediate implant placement

Exclusion Criteria:
  • Periodontally unhealthy teeth

  • Teeth with vertical root fracture on the buccal surface

  • Teeth with a horizontal fracture below the bone level

  • Teeth with external and internal resorption affecting the buccal part of the root

  • Patients who are pregnant or suspected of pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kutahya Health Sciences University Kütahya Turkey

Sponsors and Collaborators

  • Kutahya Health Sciences University

Investigators

  • Principal Investigator: Ezgi Gürbüz, Kutahya Health Sciences University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ezgi Gürbüz, Assist. Prof., Kutahya Health Sciences University
ClinicalTrials.gov Identifier:
NCT05492838
Other Study ID Numbers:
  • 02
First Posted:
Aug 9, 2022
Last Update Posted:
Aug 9, 2022
Last Verified:
Aug 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ezgi Gürbüz, Assist. Prof., Kutahya Health Sciences University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 9, 2022